Other studies showed that iPSCs generated from patients carrying insulin receptor (INSR) mutations, which causes a rare form of syndromic IR or Donohue syndrome, are inadequately self-replicative and show disruption of insulin signaling events and gene expression [16]. The gene discussed is INSR; the disease is Donohue syndrome.